BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

419 related articles for article (PubMed ID: 8522251)

  • 1. Pelvic exenteration for malignant melanomas of the vagina or urethra with over 3 mm of invasion.
    Geisler JP; Look KY; Moore DA; Sutton GP
    Gynecol Oncol; 1995 Dec; 59(3):338-41. PubMed ID: 8522251
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Melanoma of the penis, scrotum and male urethra: a 40-year single institution experience.
    Sánchez-Ortiz R; Huang SF; Tamboli P; Prieto VG; Hester G; Pettaway CA
    J Urol; 2005 Jun; 173(6):1958-65. PubMed ID: 15879790
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Malignant melanoma of the vagina: report of two cases and review of the literature.
    Greggi S; Losito S; Pisano C; Desicato S; Scaffa C
    Int Surg; 2010; 95(2):120-5. PubMed ID: 20718317
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Malignant melanoma of the vagina--report of 19 cases.
    Chung AF; Casey MJ; Flannery JT; Woodruff JM; Lewis JL
    Obstet Gynecol; 1980 Jun; 55(6):720-7. PubMed ID: 7383459
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Primary malignant melanoma of the vagina--case report and review of the literature].
    Betschart C; von Orelli S; Mihic D; Fink D
    Gynakol Geburtshilfliche Rundsch; 2007; 47(1):39-44. PubMed ID: 17272935
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Laparoscopy-assisted vaginal pelvic exenteration].
    Ferron G; Querleu D; Martel P; Chopin N; Soulié M
    Gynecol Obstet Fertil; 2006 Dec; 34(12):1131-6. PubMed ID: 17134933
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Surgical salvage of recurrent rectal cancer after transanal excision.
    Weiser MR; Landmann RG; Wong WD; Shia J; Guillem JG; Temple LK; Minsky BD; Cohen AM; Paty PB
    Dis Colon Rectum; 2005 Jun; 48(6):1169-75. PubMed ID: 15793645
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Primary spindle cell sarcoma of the vagina treated with neoadjuvant radiation and pelvic exenteration.
    Temkin SM; Hellmann M; Lee YC; Abulafia O
    J Low Genit Tract Dis; 2007 Apr; 11(2):105-7. PubMed ID: 17415115
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Indications for primary and secondary exenterations in patients with cervical cancer.
    Marnitz S; Köhler C; Müller M; Behrens K; Hasenbein K; Schneider A
    Gynecol Oncol; 2006 Dec; 103(3):1023-30. PubMed ID: 16890276
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Malignant melanoma of the vulva and vagina (a report of 4 cases and review of the literature)].
    Chakalova G; Kŭrlov T; Karag'ozov A
    Akush Ginekol (Sofiia); 1990; 29(6):30-3. PubMed ID: 2100949
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pelvic exenteration for gynecological malignancies: an analysis of 15 cases operated on at a single institution.
    Mäenpää JU; Kangasniemi K; Luukkaala T
    Acta Obstet Gynecol Scand; 2010; 89(2):279-83. PubMed ID: 19916881
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mesorectal lymph node involvement and prognostic implications at total pelvic exenteration for gynecologic malignancies.
    Mourton SM; Chi DS; Sonoda Y; Alektiar KM; Venkatraman ES; Barakat RR; Abu-Rustum NR
    Gynecol Oncol; 2006 Mar; 100(3):533-6. PubMed ID: 16226800
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anatomical anterior exenteration with urethral and vaginal preservation: illustrated surgical method.
    Schoenberg M; Hortopan S; Schlossberg L; Marshall FF
    J Urol; 1999 Feb; 161(2):569-72. PubMed ID: 9915450
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pelvic exenteration, University of Michigan: 100 patients at 5 years.
    Morley GW; Hopkins MP; Lindenauer SM; Roberts JA
    Obstet Gynecol; 1989 Dec; 74(6):934-43. PubMed ID: 2586960
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pelvic exenteration for primary and recurrent vulvar cancer.
    Miller B; Morris M; Levenback C; Burke TW; Gershenson DM
    Gynecol Oncol; 1995 Aug; 58(2):202-5. PubMed ID: 7622106
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MRI at the completion of chemoradiotherapy can accurately evaluate the extent of disease in women with advanced urethral carcinoma undergoing anterior pelvic exenteration.
    Gourtsoyianni S; Hudolin T; Sala E; Goldman D; Bochner BH; Hricak H
    Clin Radiol; 2011 Nov; 66(11):1072-8. PubMed ID: 21839430
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Primary amelanotic melanoma of the vagina.
    Grenader T; Isacson R; Reinus C; Rosengarten O; Barenholz O; Hyman J; Gabizon A; Beller U
    Onkologie; 2008 Sep; 31(8-9):474-6. PubMed ID: 18787356
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Malignant melanoma of the vagina: pejorative location].
    Gauthier T; Uzan C; Gouy S; Kane A; Calvacanti A; Mateus C; Robert C; Kolb F; Morice P
    Gynecol Obstet Fertil; 2012 May; 40(5):273-8. PubMed ID: 22336523
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Predictors for long-term survival after interdisciplinary salvage surgery for advanced or recurrent gynecologic cancers.
    Fleisch MC; Pantke P; Beckmann MW; Schnuerch HG; Ackermann R; Grimm MO; Bender HG; Dall P
    J Surg Oncol; 2007 May; 95(6):476-84. PubMed ID: 17192947
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The survival benefit to patients with positive sentinel node melanoma after completion lymph node dissection may be limited to the subgroup with a primary lesion Breslow thickness greater than 1.0 and less than or equal to 4 mm (pT2-pT3).
    Nowecki ZI; Rutkowski P; Michej W
    Ann Surg Oncol; 2008 Aug; 15(8):2223-34. PubMed ID: 18506535
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.